전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleAVEO Pharmaceuticals, Inc.Phase 2

Ficlatuzumab (Ficlatuzumab)

Head and Neck Basaloid Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma · Carcinoma, Squamous Cell of Head and Nec

#CarcinomaSquamousCellofHeadandNe#Antibody#Phase2#monoclonal-antibody#HeadandNeckBasaloidCarcinoma+2
Trials 3Status Active
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

Refractory and Relapsed T Cell Lymphoma · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
ADCLimited DatastaleSeagenPreclinical

Brentuximab vedotin plus Chidamide (Induction therapy-3 cycles of BvC, Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#antibody-drug-conjugate#CD30+PeripheralT-cellLymphoma+1
Trials 3Status Recruiting
CGTLimited DatastaleJuno Therapeutics, a Subsidiary…Preclinical

JCAR015 (JCAR015)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 3Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Discontinued
AntibodyCurated CorestaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+2
Trials 3Status Discontinued
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
AntibodyLimited DatastaleRochePhase 1

trastuzumab (Herceptin, MM-111 + Herceptin)

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Phase1#monoclonal-antibody#Roche
Trials 3Status Active
AntibodyLimited DatastaleRochePhase 2

rituximab (MabThera®, MabThera® (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 3Status Discontinued
CGTLimited DatastaleStephan Grupp MD PhDPhase 2

Murine CART19 (Murine CART19)

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL · Pediatric and Young Adult Patientswith H

#PediatricandYoungAdultPatientswi#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
ADCLimited DatastaleHenry Ford Health SystemPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab govetican)

Gastrointestinal Cancer · Gastrointestinal Cancer

#GastrointestinalCancer#ADC#Phase1#antibody-drug-conjugate#Henry
Trials 3Status Recruiting
CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 1

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
AntibodyLimited DatastaleNovartis PharmaceuticalsPhase 2

Secukinmab (Secukinmab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Novartis
Trials 3Status Active
AntibodyLimited DatastaleHoffmann-La RochePhase 1

Vanucizumab (Vanucizumab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#Hoffmann-La
Trials 3Status Active
AntibodyLimited DatastaleGenentech, Inc.Phase 1

XmAb24306 (XmAb24306)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#monoclonal-antibody#Genentech
Trials 3Status Active
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
AntibodyLimited DatastaleRochePreclinical

atezolizumab (Tecentriq, atezolizumab plus bevacizumab)

Hepatocellular Carcinoma; Hepatic Portal Vein Tumor Invasion · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#Antibody#Preclinical#monoclonal-antibody#HepatocellularCarcinoma+2
Trials 3Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, disitamab vedotin, sintilimab, capecitabine)

Rectal Cancer · Rectal Cancer

#RectalCancer#ADC#Phase2#antibody-drug-conjugate#RemeGen
Trials 3Status Recruiting
AntibodyLimited DatastaleMacroGenicsPhase 3

margetuximab (margetuximab)

Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#monoclonal-antibody#StageIIBreastCancer+1
Trials 3Status Active

30 / 103 pages

← PreviousNext →